Dai; Miao

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dai; Miao.The latest application filed is for "smac peptidometics useful as iap inhibitors".

Company Profile

0.19.17

Dai; Miao - Shanghai CN
Dai; Miao - Dover MA
Dai; Miao - Briarwood NY
Dai; Miao - Cambridge MA
Dai; Miao - Bairwood NY
Dai; Miao - Brianwood NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Smac Peptidometics Useful As Iap Inhibitors App 20140004101 - Chen; Zhuoliang ; et al.	2014-01-02
(S)-N-((S)-1-cyclohexyl-2-{(S)-2-[4-4-(4-fluorobenzoyl)-thiazol-2-yl]pyrro- lidin-1-yl}-2-oxoethyl)-2-methylamino-propionamide, or pharmaceutically acceptable salts thereof and their uses Grant 8,552,003 - Charest , et al. October 8, 2	2013-10-08
SMAC peptidometics useful as IAP inhibitors Grant 8,546,336 - Chen , et al. October 1, 2	2013-10-01
Benzyl and pyridinyl derivatives as modulators of the hedgehog signaling pathway Grant 8,536,168 - Dai , et al. September 17, 2	2013-09-17
Heterocyclic oxime compounds Grant 8,507,676 - Dai , et al. August 13, 2	2013-08-13
Heterocyclic hydrazone compounds Grant 8,497,368 - He , et al. July 30, 2	2013-07-30
Heterocyclic oxime compounds Grant 8,410,264 - Dai , et al. April 2, 2	2013-04-02
Smac Peptidometics Useful As Iap Inhibitors App 20130005663 - CHAREST; Mark G. ; et al.	2013-01-03
Heterocyclic Oxime Compounds App 20120302570 - DAI; Miao ; et al.	2012-11-29
Heterocyclic Hydrazone Compounds App 20120142681 - He; Feng ; et al.	2012-06-07
Pyrrolydine derivatives as IAP inhibitors Grant 8,044,209 - Charest , et al. October 25, 2	2011-10-25
Preparation and use of aryl alkyl acid derivatives for the treatment of obesity Grant 8,013,166 - Smith , et al. September 6, 2	2011-09-06
Preparation and use of aryl alkyl acid derivatives for the treatment of obesity Grant 7,968,576 - Smith , et al. June 28, 2	2011-06-28
Organic Compounds App 20110065726 - CHEN; Zhuoliang ; et al.	2011-03-17
Heterocyclic Oxime Compounds App 20110065708 - DAI; Miao ; et al.	2011-03-17
Pyrrolydine Derivatives as IAP Inhibitors App 20110015232 - Charest; Mark G. ; et al.	2011-01-20
Organic Compounds and Their Uses App 20100069368 - Dai; Miao ; et al.	2010-03-18
Preparation and use of aryl alkyl acid derivatives for the treatment of obesity App 20090270468 - Smith; Roger ; et al.	2009-10-29
Preparation And Use Of Aryl Alkyl Acid Derivatives For The Treatment Of Obesity App 20090253762 - Smith; Roger ; et al.	2009-10-08
Preparation And Use Of Aryl Alkyl Acid Derivatives For The Treatment Of Obesity App 20090197795 - Smith; Roger ; et al.	2009-08-06
Preparation and use of aryl alkyl acid derivatives for the treatment of obesity Grant 7,423,156 - Smith , et al. September 9, 2	2008-09-09
Preparation and use of aryl alkyl acid derivatives for the treatment of obesity App 20060194859 - Smith; Roger ; et al.	2006-08-31
Preparation and use of aryl alkyl acid derivatives for the treatment of obesity Grant 7,091,228 - Smith , et al. August 15, 2	2006-08-15
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists App 20050215594 - O'Connor, Stephen J. ; et al.	2005-09-29
2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists Grant 6,919,371 - O'Connor , et al. July 19, 2	2005-07-19
Preparation and use of aryl alkyl acid derivatives for the treatment of obesity App 20040224997 - Smith, Roger ; et al.	2004-11-11
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists App 20040072828 - O'Connor, Stephen J. ; et al.	2004-04-15
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists Grant 6,660,752 - O'Connor , et al. December 9, 2	2003-12-09
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists App 20030078260 - O'Connor, Stephen J. ; et al.	2003-04-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.